[Treatment of primary chronic polyarthritis with a cytostatic agent of the ethyleneimine group].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007970:Leukopenia / Q000209:etiology; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000209:etiology; D011696:Purpura, Thrombocytopenic / Q000209:etiology; D013921:Thrombocytopenia / Q000209:etiology; D014228:Triaziquone / Q000009:adverse effects / Q000627:therapeutic use*
D000305:Adrenal Cortex Hormones; D014228:Triaziquone
Behandlung der primär-chronischen Polyarthritis mit einem Zytostatikum der Athylenimin-Gruppe.